U.S. FDA Approves Expanded Use Of J & J ' s Cancer Cell Therapy U.S. FDA Approves Expanded Use Of J & J ' s Cancer Cell Therapy
The U.S. Food and Drug Administration on Friday allowed the expanded use of Johnson& Johnson and Legend Biotech ' s Carvykti cell therapy as an earlier treatment for...Reuters Health Information
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | Hematology